Pacific Biosciences of California (PACB) — Financial Flexibility Index
Pacific Biosciences of California (PACB) has a Financial Flexibility Index of -0.10x as of June 2026. Free cash flow of $-75.68 Million (operating CF $-80.27 Million minus capex $4.60 Million) represents 0% of total liabilities ($785.06 Million). Check Pacific Biosciences of California (PACB) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pacific Biosciences of California Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Pacific Biosciences of California across 18 annual periods. For the full cash flow conversion analysis, see Pacific Biosciences of California (PACB) cash conversion ratio.
Annual Financial Flexibility Index for Pacific Biosciences of California (2008–2025)
Year-by-year free cash flow to debt coverage for Pacific Biosciences of California. Explore debt repayment capacity of Pacific Biosciences of California to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.14x | $-108.50 Million | $-111.21 Million | $778.73 Million | ▲ +47.5% |
| 2024 | -0.27x | $-199.87 Million | $-206.06 Million | $753.85 Million | ▼ -7.5% |
| 2023 | -0.25x | $-257.70 Million | $-266.55 Million | $1.04 Billion | ▼ -20.6% |
| 2022 | -0.20x | $-246.28 Million | $-263.21 Million | $1.20 Billion | ▼ -136.3% |
| 2021 | -0.09x | $-105.25 Million | $-111.18 Million | $1.22 Billion | ▼ -133.1% |
| 2020 | 0.26x | $20.54 Million | $19.50 Million | $78.49 Million | ▲ +132.3% |
| 2019 | -0.81x | $-75.48 Million | $-78.31 Million | $93.07 Million | ▲ +29.4% |
| 2018 | -1.15x | $-64.58 Million | $-66.43 Million | $56.21 Million | ▼ -16.7% |
| 2017 | -0.98x | $-57.09 Million | $-67.52 Million | $57.98 Million | ▲ +12.3% |
| 2016 | -1.12x | $-59.72 Million | $-67.93 Million | $53.22 Million | ▼ -44.0% |
| 2015 | -0.78x | $-44.88 Million | $-47.89 Million | $57.57 Million | ▼ -8.8% |
| 2014 | -0.72x | $-49.86 Million | $-51.47 Million | $69.57 Million | ▼ -66.0% |
| 2013 | -0.43x | $-28.92 Million | $-29.83 Million | $67.00 Million | ▲ +88.3% |
| 2012 | -3.70x | $-75.12 Million | $-76.82 Million | $20.30 Million | ▼ -6.1% |
| 2011 | -3.49x | $-93.69 Million | $-102.97 Million | $26.85 Million | ▲ +22.6% |
| 2010 | -4.51x | $-116.74 Million | $-122.00 Million | $25.88 Million | ▼ -1701.5% |
| 2009 | -0.25x | $-69.66 Million | $-74.84 Million | $278.22 Million | ▼ -58.6% |
| 2008 | -0.16x | $-32.60 Million | $-38.30 Million | $206.50 Million | — |